Sentire Medical Systems
Sentire Medical Systems is dedicated to advancing patient safety through innovative medical technology. Their flagship product, Perf-Alert®, is a patented, non-invasive monitoring system designed to detect bowel perforations during laparoscopic surgeries, enabling immediate intraoperative repair and significantly reducing associated risks, costs, and patient morbidity.
Industries
Nr. of Employees
small (1-50)
Sentire Medical Systems
Products
Intraoperative bowel perforation monitoring system
A non-invasive intraoperative monitoring system designed to detect signals indicative of bowel perforation during laparoscopic surgery and to provide real-time alerts to surgeons to enable immediate repair.
Intraoperative bowel perforation monitoring system
A non-invasive intraoperative monitoring system designed to detect signals indicative of bowel perforation during laparoscopic surgery and to provide real-time alerts to surgeons to enable immediate repair.
Services
Collaborations with research institutions and national laboratories to develop and advance surgical monitoring technologies; engagement includes joint projects and fellowship participation.
Pursuit and management of government research grants and SBIR awards to fund development of surgical monitoring technologies.
Collaborations with research institutions and national laboratories to develop and advance surgical monitoring technologies; engagement includes joint projects and fellowship participation.
Pursuit and management of government research grants and SBIR awards to fund development of surgical monitoring technologies.
Expertise Areas
- Intraoperative monitoring for laparoscopic surgery
- Clinical trial execution and publication
- Medical device research and development
- Regulatory compliance and device commercialization
Key Technologies
- Intraoperative surgical sensing
- Non-invasive monitoring systems
- Biomedical sensor integration
- Photonics and spectroscopy-based sensing
News & Updates
In November 2024, Sentiré Medical Systems received a Science and Technology grant, supporting their ongoing innovation efforts.
In February 2024, the company announced a collaboration with Los Alamos National Laboratory and recognized Devin Fell as a ‘Deep Tech’ fellow.
In February 2023, the company was awarded a second SBIR grant from NSF.
In May 2020, the company received Phase 1 SBIR grant from NSF.
In January 2019, the successful study and publication of Perf-Alert® system testing at Stanford University.
In March 2018, the company was awarded a U.S. patent for methods and devices for detecting bowel perforation.
In November 2024, Sentiré Medical Systems received a Science and Technology grant, supporting their ongoing innovation efforts.
In February 2024, the company announced a collaboration with Los Alamos National Laboratory and recognized Devin Fell as a ‘Deep Tech’ fellow.
In February 2023, the company was awarded a second SBIR grant from NSF.
In May 2020, the company received Phase 1 SBIR grant from NSF.
In January 2019, the successful study and publication of Perf-Alert® system testing at Stanford University.
In March 2018, the company was awarded a U.S. patent for methods and devices for detecting bowel perforation.